ELAVL1 also plays an essential function in tumours such as colorectal cancer (Gu et al., 2019) and breast cancer (Chou et al., 2015; Luo et al., 2020), suggesting that ELAVL1 may indeed serve as a potential marker for PAAD. This evidence concerns the gene ELAVL1 and pancreatic adenocarcinoma.